Autopsy report · NCT01345968

Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery

“Less patients than expected for inclusion, therefore recruitment is too low”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University Hospital Muenster

Sponsor type

University, hospital or other

Conditions

Anemia; Orthopedic Surgery; High Risk of Blood Loss

Interventions

Ferinject 50 mg/ml; NaCl 0.9%

Participants

3

Sites

2

Countries

Germany

Trials that died the same way

• Vitamin D Levels In Patients Who Has Normal to Grade 2 Knee Arthroscopy Changes
  “Lack of patients with recruitment criteria” (85% match in meaning)
• The Risk of Intraventricular Hemorrhage With Flat Midline Versus Right-Tilted Flat Lateral Head Positions
  “Due to low patient recruitment” (83% match in meaning)
• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
  “Patient recruitment insufficient” (82% match in meaning)
• SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
  “Low patient recruitment” (82% match in meaning)
• Esophageal Balloon Guided Weaning of the Morbidly Obese Patient
  “Minimal recruitment. very few patients available with eligibility criteria” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.